Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
0.7909
-0.0461 (-5.51%)
Jun 18, 2026, 9:53 AM EDT - Market open
Arcadia Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.76 | 4.86 | 5.05 | 4.45 | 7.42 | 6.78 | |
Revenue Growth (YoY) | -9.53% | -3.71% | 13.27% | -39.96% | 9.41% | -15.61% |
Cost of Revenue | 3.12 | 3.1 | 2.96 | 2.17 | 6.1 | 8.71 |
Gross Profit | 1.64 | 1.76 | 2.08 | 2.28 | 1.32 | -1.93 |
Selling, General & Admin | 6.44 | 7 | 9.64 | 8.23 | 15.04 | 22.94 |
Research & Development | 0.01 | 0.01 | 0.05 | 0.06 | 1.51 | 3.89 |
Other Operating Expenses | -1 | -2.75 | -3.96 | 0.08 | -1.22 | 6.77 |
Total Operating Expenses | 5.45 | 4.26 | 5.73 | 8.38 | 15.32 | 33.6 |
Operating Income | -3.03 | -2.5 | -3.65 | -6.1 | -14.01 | -35.53 |
Interest Income | 0.02 | 0.22 | 0.78 | 0.7 | 0.29 | - |
Interest Expense | - | - | - | - | - | -0.02 |
Other Non-Operating Income (Expense) | -5.53 | -0.05 | -1.44 | 0.09 | 2.9 | 19.41 |
Total Non-Operating Income (Expense) | -5.51 | 0.17 | -0.66 | 0.78 | 3.19 | 19.39 |
Pretax Income | -8.54 | -2.33 | -4.31 | -5.32 | -10.81 | -16.13 |
Provision for Income Taxes | - | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
Net Income | -8.54 | -2.34 | -4.32 | -13.99 | -15.61 | -16.13 |
Minority Interest in Earnings | - | - | - | 0.01 | 0.24 | 1.47 |
Earnings From Discontinued Operations | - | - | -2.72 | -8.66 | -4.78 | - |
Net Income to Common | -9.32 | -2.34 | -7.04 | -13.98 | -15.38 | -14.66 |
Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 1 | 1 |
Shares Change (YoY) | 13.48% | 0.35% | 10.22% | 106.36% | 12.66% | 113.68% |
EPS (Basic) | -5.71 | -1.71 | -5.17 | -4.30 | -17.67 | -27.56 |
EPS (Diluted) | -5.72 | -1.71 | -5.17 | -4.30 | -17.67 | -27.56 |
Free Cash Flow | -4.25 | -4.74 | -9.64 | -15.3 | -14.05 | -26.88 |
Free Cash Flow Per Share | -2.74 | -3.46 | -7.07 | -12.37 | -23.44 | -50.52 |
Gross Margin | 34.49% | 36.23% | 41.27% | 51.19% | 17.75% | -28.44% |
Operating Margin | -63.64% | -51.46% | -72.31% | -137.00% | -188.82% | -523.98% |
Profit Margin | -179.40% | -48.15% | -85.57% | -314.01% | -210.46% | -237.96% |
FCF Margin | -89.32% | -97.55% | -191.14% | -343.49% | -189.39% | -396.39% |
EBITDA | -2.98 | -2.35 | -2.88 | -5.12 | -12.64 | -33.21 |
EBITDA Margin | -62.69% | -48.29% | -57.15% | -114.91% | -170.45% | -489.75% |
EBIT | -3.03 | -2.5 | -3.65 | -6.1 | -14.01 | -35.53 |
EBIT Margin | -63.64% | -51.46% | -72.31% | -137.00% | -188.82% | -523.98% |
Effective Tax Rate | - | -0.34% | -0.19% | -0.15% | -0.13% | -0.01% |